PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Sweating, Gustatory”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 397 records · Page 22Linked to original sources

A comparison of one hundred and fifty consecutive parotidectomies for tumours and inflammatory disease.

The demographic profile and complications are compared and contrasted for 150 consecutive parotidectomies. All patients were under the care of one surgeon (JDL) over a twenty-year period (1977-1997). The case records and contemporaneous database were analysed retrospectively. 111 (74%) procedures were performed for tumours and 39 (26%) for inflammatory disease. The incidence of unexpected permanent facial nerve palsy was 1.8% in the tumour group and zero in the inflammatory group. The overall unexpected palsy rate was 1.3%. Transient paralysis was more common in the inflammatory group than the tumour group (61.5% compared with 33.3%, P<0.02) and was more likely to be panfacial (48.7% compared with 17.1%, P<0.0002). The overall incidence of Frey's syndrome was less than 20% and both salivary fistulae and sialocoeles were infrequent.

Adolescent↗

[Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A].

Based upon an inception cohort of 30 patients with severe Frey's syndrome, after conservative parotidectomy, the technique and the results of intracutaneous injection of botulinum toxin type A are presented. The skin surface involved with Frey's syndrome was managed with intracutaneous injection of 2.5 international units of botulinum toxin type A per square centimeter. A minimum follow-up of 16 months was achieved. The only adverse side effect encountered was a temporary paresis of the upper lid noted in 2 patients. Frey's syndrome vanished within 2-5 days from the intracutaneous injection of botulinum toxin type A. Frey's syndrome was controlled in 53.2% of cases (17/30) after the initial injection of botulinum toxin type A. Five of the 13 patients with recurrence of Frey's syndrome elicited to undergo a watch and wait policy due to the lack of discomfort induced by the recurrence. The remaining eight patients with recurrence of Frey's syndrome were successfully managed with a secondary intracutaneous injection of botulinum toxin type A. Such preliminary data, together with the review of the literature suggests, that the intracutaneous injection of botulinum toxin type A should now be the first line treatment option in patients with severe Frey syndrome.

Adolescent↗

Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases.

In a personal series of 162 tumours, 101 were pleomorphic adenomas 28 of which were removed by elective local extra capsular dissection and 73 by a conventional nerve dissection. There were no recurrences in either group after a mean follow-up 10.3 years, range 3-21 years for local dissection and 8.3 years, range 3-22 years for nerve dissection. Frey's syndrome did not occur after local dissection but was present in 25% of patients after a nerve dissection. Of the 162 parotid lumps, 17 proved to be a carcinoma but only one was deemed suitable for a local removal, a low grade muco epidermoid carcinoma of the accessory lobe and no recurrence has occurred after 8 years. In benign disease, local dissection gives similar results to conventional nerve dissection with less morbidity and confirms that tumour recurrence cannot be ascribed to any properties of the tumour but lies in the hands of the surgeon and depends on the care with which the tumour is removed.

Adenoma, Pleomorphic↗

[Frey syndrome: diagnosis and treatment].

Observed lately increased of the Lucie Frey's syndrom occurance is related to advanced frequency of the parotid gland surgery, especially because of neoplasmic lesions of the gland. Symptoms which follow partial or total parotidectomy are very bothersome for patients and unfortunately they strengthening with a lapse of a time. For applied pharmacotherapy outcomes are in fact dubious. In this light the recently applicated clostridium botulinum toxin of type A deserves of special attention as patient therapeutic agent for Frey's syndrome because of very promising results which can last for several months and even years. At first discussing the anatomopatholophysiology as well as diagnostic tests. The authors present their own experience as well as results obtained in application of the botulin toxin for therapy of the Lucie Frey syndrome.

Botulinum Toxins, Type A↗

Parotid swellings: report of 110 consecutive cases.

Parotid swellings are uncommon. Over a twelve-year period, 110 cases of parotid swellings were treated at the Department of Plastic Surgery, Hospital Kuala Lumpur, of which 97 cases were histologically proven to be parotid tumours. 75% of these tumours were benign tumours, and 80% of the benign tumours were pleomorphic adenomas. Among the malignant tumours, 6 cases were adenoid cystic carcinoma and 5 were carcinoma ex-pleomorphic adenoma. There were equal number of male to female patients, with an age range of 14 to 83 years. There is a positive correlation between the final histological diagnosis and FNAC results in 74% of cases. Surgical treatment of choice for benign parotid tumours was near-total parotidectomy whilst for malignant tumours was total radical parotidectomy with sural nerve graft.

Adolescent↗

[Advantage of lifting in parotidectomy].

INTRODUCTION: A retrospective study is presented of surgical patients undergoing simultaneous SMAS lifting technique and parotidectomy, with evaluation of the incidence of clinical Frey's syndrome. METHODS: 40 patients were operated on between 1978 and 1999. The surgical technique is described and the incidence of clinical Frey's syndrome as evaluated by questionnaire is presented. RESULTS: The 36 patients who answered the questionnaire were satisfied with the aesthetic result in terms of hidden scar and defect filling. 2 patients complained of warm cheek sensation during meals, without associated sweating. One patient who had had superficial parotidectomy in 1978 and total parotidectomy for recurrent pleomorphic adenoma in 1997 complained of Frey's syndrome. CONCLUSION: Combination of the two techniques provides excellent aesthetic results. In this study the incidence of clinical Frey's syndrome was 2%, with an incidence of incomplete Frey's syndrome in 5.5% of cases due to SMAS interposition.

Adenoma↗

Pleomorphic adenoma.

Pleomorphic adenoma is the most common neoplasm of the salivary glands. Though a benign lesion, proper recognition and management of this process is needed to avoid increasing enlargement of the mass, facial nerve impairment, risk of malignant degeneration, and recurrence after surgical resection. The epidemiology, diagnosis, and treatment options for this neoplasm are discussed.

Adenoma, Pleomorphic↗

[Abnormalities of recovery of the facial nerve].

This paper presents 235 cases of facial palsy. These cases are part of a group of 455 cases and they were chosen because their clinical study and evolution were well documented. Abnormalities of facial nerve recovery are described and the importance of each one with reference to the group is determined. Two cases of particular interest are described, and comments are offered on the incidence of abnormality of recovery according to the type of lesion and to the importance of the electrical dysfunction.

Age Factors↗